Rotate to portrait

Vizual Stocks works best vertically on mobile.

VizualStocks API
PUBLIC DATA DEFINITIONS

Gilead Sciences KPI & segment coverage

Operating KPI and segment definitions available for Gilead Sciences (GILD) through the VizualStocks API.

GILD2 metric seriesCatalog checked 2026-10-28
Metric catalog API reference Open in the interactive demo

Active metrics 2

SEGMENT

Product Sales Revenue

Net sales of Gilead medicines for HIV treatment and prevention, liver disease, oncology and cell therapy, plus Veklury for COVID-19. The total is reported after rebates, chargebacks, co-pay assistance, discounts, distributor fees and estimated returns.

productSalesRevenue
Frequency
quarterly / annual
Reported history
Q1'14 — Q2'26
History endpoint
SEGMENT

Royalty Contract And Other Revenue

Revenue from royalties on intellectual property licensed to partners, sales of intellectual property and other payments under third-party collaboration agreements. This line can be uneven because milestone, contract or IP-sale revenue may be recognized in a single period.

royaltyContractAndOtherRevenue
Frequency
quarterly / annual
Reported history
Q1'14 — Q2'26
History endpoint